PASSAGE BIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
PASSAGE BIO, INC. (PASG) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 647.62 thousand shares as of 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2026-09-03
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 647.62K shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 846.11K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 658.97K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 669.56K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
|---|---|
| 2026-06-30 | 647.62K shares S-4/A · filed 2026-09-03 |
| 2026-03-31 | 846.11K shares S-4 · filed 2026-07-21 |
| 2025-12-31 | 658.97K shares S-4/A · filed 2026-09-03 |
| 2025-09-30 | 669.56K shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 726.59K shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 14.10M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 11.55M shares 10-K · filed 2025-03-04 |
| 2024-09-30 | 12.01M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 12.45M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 12.39M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 9.29M shares 10-K · filed 2024-03-04 |
| 2023-09-30 | 10.24M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 13.55M shares 10-Q · filed 2023-08-07 |
| 2023-03-31 | 13.61M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 11.41M shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 11.74M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 11.98M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 10.65M shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 9.42M shares 10-K · filed 2022-03-03 |
| 2021-09-30 | 9.49M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 8.70M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 8.71M shares 10-Q · filed 2021-05-05 |
| 2020-12-31 | 6.93M shares 10-K · filed 2021-03-03 |
| 2020-09-30 | 6.61M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 6.36M shares 10-Q · filed 2020-08-13 |
| 2020-03-31 | 5.91M shares 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |